Washington D.C. [US], May 2 (Sputnik/ANI): The US Food and Drug Administration has authorized an emergency use of Remdesivir drug in coronavirus treatment, FDA head Stephen Hahn announced on Friday."We authorized [a pharmaceutical company] Gilead's application for emergency use authorization for the use of Remdesivir in hospitalized patients," Hahn said at a White House event.US President Donald Trump called Remdesivir use "a hot thing" and "really, a very promising situation."Gilead CEO Daniel O'Day announced that the company is donating 1.5 million vials of the medicine."We made a decision to donate about 1.5 million vials of Remdesivir. We will be working with the government to determine how best to distribute that. Gilead is fully committed to continue to expand the supply of the medicine," O'Day said.O'Day added that Remdesivir clinical trials started immediately when the manufacturer saw "COVID-19 circulating." (Sputnik/ANI)

(The above story is verified and authored by ANI staff, ANI is South Asia's leading multimedia news agency with over 100 bureaus in India, South Asia and across the globe. ANI brings the latest news on Politics and Current Affairs in India & around the World, Sports, Health, Fitness, Entertainment, & News. The views appearing in the above post do not reflect the opinions of LatestLY)